Kraskovskaya N, Linkova N, Sakhenberg E, Krieger D, Polyakova V, Medvedev D, et al
Subscribe to save 20% and keep your routine uninterrupted
As a Houston podiatrist with over 25 years in practice, I've watched regenerative medicine go from fringe conversation to front-line treatment
NICE guidance (NG28) recommends GLP-1 receptor agonists for type 2 diabetes in specific clinical circumstances, typically when metformin and other treatments have not achieved glycaemic targets
However, what professionals have found over time is that their patients were also losing weight while treating their diabetes
These reports appear anecdotal rather than supported by robust clinical evidence